• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ayahuasca Treatment Outcome Project (ATOP): One-Year Results from Takiwasi Center and Implications for Psychedelic Science.迷幻剂治疗结果项目(ATOP):塔基瓦西中心的一年期结果及其对迷幻科学的启示。
J Stud Alcohol Drugs. 2024 Sep;85(5):607-618. doi: 10.15288/jsad.23-00005. Epub 2023 Aug 24.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
4
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.创伤后应激障碍及共病物质使用障碍的心理治疗
Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2.
5
Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.探索在自然静修环境中给予退伍军人迷幻药的治疗效果。
Brain Behav. 2025 Jul;15(7):e70660. doi: 10.1002/brb3.70660.
6
Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies.安非他命和其生物碱对物质使用障碍的影响:一项更新的(2016-2020)关于临床前和人体研究的系统综述。
Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):541-556. doi: 10.1007/s00406-021-01267-7. Epub 2021 Apr 29.
7
Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT.功能性运动障碍专科物理治疗的效果:Physio4FMD随机对照试验
Health Technol Assess. 2025 Jul;29(34):1-28. doi: 10.3310/MKAC9495.
8
Pharmacotherapy for anxiety and comorbid alcohol use disorders.焦虑症合并酒精使用障碍的药物治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
Investigation and analysis of mental health status of the older adult in western rural areas.西部农村地区老年人心理健康状况的调查与分析
Front Public Health. 2025 Jul 16;13:1612600. doi: 10.3389/fpubh.2025.1612600. eCollection 2025.

引用本文的文献

1
Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.用于酒精使用障碍的迷幻剂:一项具有候选作用机制的叙述性综述。
CNS Drugs. 2025 Jul 10. doi: 10.1007/s40263-025-01199-z.
2
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.与自然主义使用死藤水相关的长期心理健康和幸福结果。
J Psychoactive Drugs. 2025 Feb 20:1-11. doi: 10.1080/02791072.2025.2465800.

本文引用的文献

1
An International, Multidisciplinary Consensus Set of Patient-Centered Outcome Measures for Substance-Related and Addictive Disorders.一份关于物质相关及成瘾性障碍的以患者为中心的国际多学科共识结局指标集。
J Clin Med. 2024 Apr 8;13(7):2154. doi: 10.3390/jcm13072154.
2
Ancient medicine for a modern disease: traditional Amazonian medicine to treat substance use disorders.现代疾病的古代医学:用传统亚马逊医学治疗物质使用障碍
Am J Drug Alcohol Abuse. 2023 Nov 2;49(6):691-704. doi: 10.1080/00952990.2023.2264466. Epub 2023 Dec 11.
3
Ayahuasca's therapeutic potential: What we know - and what not.阿亚瓦斯卡的治疗潜力:我们所知道的——以及未知的。
Eur Neuropsychopharmacol. 2023 Jan;66:45-61. doi: 10.1016/j.euroneuro.2022.10.008. Epub 2022 Nov 8.
4
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.裸盖菇素辅助心理治疗与安慰剂治疗酒精使用障碍成年患者后重度饮酒日的百分比:一项随机临床试验。
JAMA Psychiatry. 2022 Oct 1;79(10):953-962. doi: 10.1001/jamapsychiatry.2022.2096.
5
Protocol for Outcome Evaluation of Ayahuasca-Assisted Addiction Treatment: The Case of Takiwasi Center.死藤水辅助成瘾治疗的结果评估方案:以塔基瓦西中心为例。
Front Pharmacol. 2021 May 19;12:659644. doi: 10.3389/fphar.2021.659644. eCollection 2021.
6
Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety.一项结合传统亚马逊草药、阿育吠陀和心理治疗的住宅药物成瘾治疗对抑郁和焦虑的初步评估。
J Psychoactive Drugs. 2020 Nov-Dec;52(5):472-481. doi: 10.1080/02791072.2020.1789247. Epub 2020 Aug 4.
7
A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial.单次氯胺酮输注联合动机增强治疗酒精使用障碍:一项随机咪达唑仑对照的先导试验。
Am J Psychiatry. 2020 Feb 1;177(2):125-133. doi: 10.1176/appi.ajp.2019.19070684. Epub 2019 Dec 2.
8
Exploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada.探索安非他命辅助治疗成瘾:在加拿大一个原住民社区中初步研究结果的定性分析。
Drug Alcohol Rev. 2019 Nov;38(7):781-789. doi: 10.1111/dar.12985. Epub 2019 Sep 5.
9
Short-Term Treatment Effects of a Substance Use Disorder Therapy Involving Traditional Amazonian Medicine.涉及传统亚马逊草药的物质使用障碍治疗的短期治疗效果。
J Psychoactive Drugs. 2019 Sep-Oct;51(4):323-334. doi: 10.1080/02791072.2019.1607956. Epub 2019 May 1.
10
[Practices in search of legitimacy: the contemporary use of ayahuasca, between religious and therapeutic vindications].寻求合法性的实践:当代对死藤水的使用,介于宗教与治疗主张之间
Salud Colect. 2018 Apr-Jun;14(2):341-354. doi: 10.18294/sc.2018.1539.

迷幻剂治疗结果项目(ATOP):塔基瓦西中心的一年期结果及其对迷幻科学的启示。

Ayahuasca Treatment Outcome Project (ATOP): One-Year Results from Takiwasi Center and Implications for Psychedelic Science.

机构信息

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Rory Meyers College of Nursing, New York University, New York, New York.

出版信息

J Stud Alcohol Drugs. 2024 Sep;85(5):607-618. doi: 10.15288/jsad.23-00005. Epub 2023 Aug 24.

DOI:10.15288/jsad.23-00005
PMID:37615330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11533928/
Abstract

OBJECTIVE

This article focuses on the outcomes at 1 year post-treatment of a naturalistic evaluation of services provided through the Takiwasi Centre, an accredited Peruvian therapeutic community offering an ayahuasca-assisted, integrative treatment program for addiction rehabilitation.

METHOD

Participants ( = 52) completed structured interviews and a battery of validated instruments. Outcome measures included the Addiction Severity Index (Version 5), the Beck Anxiety and Depression Inventories, the World Health Organization Quality of Life Brief Version (WHOQOL-BREF), and the World Health Organization Quality of Life Spiritual Religious and Personal Belief (WHOQOL-SRPB) scale. Likert rating scales were used to assess perceived importance and significance of different aspects of the program and overall participant satisfaction.

RESULTS

The group change from baseline to the 1-year follow-up was significant and in the anticipated direction for alcohol and drug use severity, depression and anxiety, and some dimensions of quality of life. There was considerable individual variation in outcomes and treatment duration. The majority of participants rated all aspects of the program as important, including the spiritual and therapeutic significance of the ayahuasca experience, which was rated as very significant.

CONCLUSIONS

Based on the positive 1-year outcomes, and within the limitations of an uncontrolled observational study design, the findings suggest promise for the effectiveness of the use of ayahuasca in a multifactorial treatment context for individuals with significant treatment histories, high levels of comorbidity, and treatment motivation. Results highlight considerable variation in individual experience that merit in-depth qualitative analysis. Implications for ayahuasca-assisted and other psychedelic-assisted treatment alternatives are discussed.

摘要

目的

本文聚焦于塔基瓦西中心服务治疗效果的 1 年随访结果。塔基瓦西中心是一家经认证的秘鲁治疗社区,提供以安非他命类兴奋剂致瘾康复为目的的、包含使用植物致幻剂辅助治疗的综合性治疗方案。

方法

参与者(n=52)完成了结构式访谈和一系列验证工具的测试。评估的结果包括:成瘾严重程度指数(第 5 版)、贝克焦虑和抑郁量表、世界卫生组织生活质量简短量表(WHOQOL-BREF)和世界卫生组织生活质量精神宗教和个人信仰量表(WHOQOL-SRPB)。采用李克特量表来评估参与者对不同治疗方案和整体治疗满意度的重要性和意义。

结果

从基线到 1 年随访的时间内,该治疗方案显著改善了酒精和药物使用严重程度、抑郁和焦虑症状以及部分生活质量维度,变化方向与预期一致。但治疗效果在个体间存在显著差异,且治疗时间也存在差异。大多数参与者对治疗方案的所有方面都给予了高度评价,包括植物致幻剂治疗体验的精神和治疗意义,评价结果非常重要。

结论

基于积极的 1 年随访结果,以及非对照观察性研究设计的局限性,本研究结果表明,对于具有高治疗史、高共病率和高治疗动机的个体来说,在多因素治疗环境中使用植物致幻剂治疗具有潜在的有效性。研究结果突出了个体体验的巨大差异,这值得进行深入的定性分析。最后讨论了植物致幻剂辅助治疗及其他致幻剂辅助治疗方案的应用前景。